In each tissue in which tetramer-binding cells were found most of these cells were also CD8+ and localized in T cell zones [12], [16] (Figures 1, 2 and 3).
However, ML2 cells were found resistant to lysis mainly due to deficient perforin binding [ 8, 10].
Using in vitro dose titration experiments with different amounts of trastuzumab (ranging from 0.05 to 1.5 μg ml−1), binding of USC cells was found to plateau at a trastuzumab concentration ranging from 0.5 to 1 μg ml−1.
The output/input ratio of phages after each round of panning was used to determine the phage recovery efficiency and an obvious enrichment of phages specifically binding to BCG γδ T cells was found (Table 1).
Cross-linking of 125I-labelled TGF-beta1 to melanoma cells, Mel 97, by disuccinimidyl suberate (DSS) demonstrated that CD105 expressed on pigmented cells binds TGF-beta1; the pattern of binding of TGF-beta1 to melanoma cells was found to be similar to that of human umbilical vein endothelial cells.
The binding specificity of iRGD-MBs for endothelial cells was found to be significantly stronger than that of control MBs (p < 0.01) under in vitro static and dynamic conditions.
Microinjection of profilin, a monomeric actin binding protein, into dividing Tradescantia stamen hair cells was found to disrupt phragmoplast-associated MFs and to inhibit cell plate expansion [ 27].
In 45 cases in Ramos cells and 9 cases in BEAS2B cells, STAT6 binding sites were found to be associated with previously uncharacterized putative alternative promoters of protein-coding genes (left panel; Fig. 1B).
On the other hand, less than 100 promoter binding sites were found in cells prior to H2O2 treatment.
We found that the median enrichment level of the overlapping Atf1 binding sites in cells under both conditions was clearly higher than that of the non-overlapping binding sites (i.e., the binding sites that were found in cells under only one of two conditions) (3.6 4.0-fold 3.6 4.0-foldold higher than the array median; p-versus2.4-fold (Figure 1D, see M).
The peptides were tested in binding assays involving U937 and A549 cells; two high activity binding peptides (HABPs) were found for both cell lines (39226-1MSYMIATPAALTAAATDIDGI21 and 39232-125YQRHFGTGGQPEFRQHSEHRR144), one for U937 (39231-104YandGRRQRRRRSGDGQWRLRQ124) and one for A549 (39230-83YGTGVFRRRRGRQTVTA549RA549).
